Diacerin for the Treatment of Epidermolysis Bullosa Simplex

Clinical trial NCT02470689 · UNKNOWN

Trial details

NCT number: NCT02470689
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex

Start date: 2015-06-01
Primary completion: 2017-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.